Form 8-K - Current report:
SEC Accession No. 0001104659-25-040386
Filing Date
2025-04-29
Accepted
2025-04-28 20:00:46
Documents
14
Period of Report
2025-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513409d1_8k.htm   iXBRL 8-K 34875
2 EXHIBIT 10.1 tm2513409d1_ex10-1.htm EX-10.1 130938
  Complete submission text file 0001104659-25-040386.txt   365242

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA glyc-20250428.xsd EX-101.SCH 3029
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE glyc-20250428_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glyc-20250428_pre.xml EX-101.PRE 22368
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2513409d1_8k_htm.xml XML 3540
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 25882256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)